Pharma & Healthcare
Alpha 1 Antitrypsin Deficiency Treatment
Alpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests as chronic obstructive pulmonary disease (including bronchiectasis) and liver disease (especially cirrhosis and hepatoma), or more rarely, as a skin condition called panniculitis. A1AD is also more frequent among…
- Types
- Augmentation Therapy · Cystic Fibrosis(CF) · Non-CF Bronchiectasis(NCFB)
- Applications
- COPD · Cystic Fibrosis(CF) · Non-CF Bronchiectasis(NCFB)
5 editions29 December 2025
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Alpha 1 Antitrypsin Deficiency TreatmentCompare research options for Alpha 1 Antitrypsin Deficiency Treatment